VSTM Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
24.0M
-40.1%
40.1M
+114.7%
18.7M
+6.5%
17.5M
+56.0%
11.2M
Cost of Revenue
3.9M
-2.4%
4.0M
+32.4%
3.1M
+16.8%
2.6M
+33.3%
2.0M
Gross Profit
20.1M
-44.3%
36.0M
+130.7%
15.6M
+4.7%
14.9M
+60.8%
9.3M
Operating Expenses
95.3M
+38.6%
68.7M
+13.6%
60.5M
+7.3%
56.4M
+12.8%
50.0M
R&D
68.8M
+66.4%
41.3M
+8.2%
38.2M
+20.7%
31.7M
+9.3%
29.0M
SG&A
26.5M
-3.4%
27.4M
+22.9%
22.3M
-8.8%
24.4M
+16.4%
21.0M
Operating Income
-75224000
-130.0%
-32710000
+27.1%
-44897000
-8.3%
-41475000
-1.9%
-40715000
EBITDA
-74945000
-131.1%
-32430000
+27.3%
-44618000
-9.5%
-40759000
-0.8%
-40423000
Net Income
-74723000
-115.5%
-34673000
+5.2%
-36591000
-11.2%
-32916000
+66.6%
-98518000
EPS (Basic)
$-0.74
-111.4%
$-0.35
+5.4%
$-0.37
+5.1%
$-0.39
+71.1%
$-1.35
EPS (Diluted)
$-0.74
-111.4%
$-0.35
+23.9%
$-0.46
-7.0%
$-0.43
+68.1%
$-1.35
Shares (Diluted)
101.2M
+1.1%
100.1M
+1.0%
99.1M
+30.7%
75.9M
+3.7%
73.2M
Verastem (VSTM) — Financials